BOLT — Bolt Biotherapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-02-05.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-12-05 | Quinn William P. President, CEO and CFO | Open-market purchase | 125 | 4.61 | 576 |
| 2025-12-05 | Nemec Sarah Senior VP, Finance and PAO | Open-market purchase | 125 | 4.61 | 576 |
| 2025-10-22 | Quinn William P. President, CEO and CFO | Grant or award | 40.0K | 0.00 | 0 |
| 2025-10-22 | Nemec Sarah Senior VP, Finance and PAO | Grant or award | 23.0K | 0.00 | 0 |
| 2025-10-22 | Yonehiro Grant Chief Operating Officer | Grant or award | 30.0K | 0.00 | 0 |
| 2025-06-06 | Quinn William P. President, CEO and CFO | Open-market purchase | 125 | 5.49 | 686 |
| 2025-06-06 | Nemec Sarah Senior VP, Finance and PAO | Open-market purchase | 125 | 5.49 | 686 |
| 2024-12-16 | Nemec Sarah Senior VP, Finance and PAO | Open-market purchase | 2.5K | 0.50 | 1.2K |
| 2024-12-16 | Quinn William P. President, CEO and CFO | Open-market purchase | 2.5K | 0.50 | 1.2K |
| 2024-06-06 | Quinn William P. President, CEO and CFO | Open-market purchase | 2.5K | 0.64 | 1.6K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| SCHEDULE 13G | 2026-08-13 | — | on EDGAR ↗ |
| 10-Q | 2026-08-11 | 2026-06-30 | on EDGAR ↗ |
| 8-K | 2026-08-11 | 2026-08-11 | on EDGAR ↗ |
| 4 | 2026-06-11 | 2026-06-10 | on EDGAR ↗ |
| 4 | 2026-06-11 | 2026-06-10 | on EDGAR ↗ |
| 4 | 2026-06-11 | 2026-06-10 | on EDGAR ↗ |
| 4 | 2026-06-11 | 2026-06-10 | on EDGAR ↗ |
| 4 | 2026-06-11 | 2026-06-10 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about BOLT
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →